Clinical trial
1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention (ADAPT-DCB)
NCT07879430 is registered in ClinicalTrials.gov with Ulsan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention (ADAPT-DCB)
- Lead sponsor
- Ulsan University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 19, 2026
- Completion date
- October 31, 2029
- Enrollment
- 1,258 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad)